Presentation
7 March 2022 Performance assessment of commercial continuous-wave near-infrared spectroscopy devices for the multi-center HEMOCOVID-19 clinical study
Author Affiliations +
Abstract
During the first peak of the COVID-19 pandemic, we have set up a clinical campaign in ten hospitals worldwide to assess the endothelial health of COVID-19 patients using commercial continuous-wave near-infrared spectroscopy (CW-NIRS) devices (PortaMon, Artinis, NL). In spite of the wide range of clinical applications, the reliability of common CW-NIRS systems for absolute oxygenation measurements was often questioned, opening issues of standardization. In addition, a multi-center trial itself opens issues about how to compare measurements performed by different operators, in different conditions and longitudinally over more than a year. Here, we present how we address these challenges by characterizing and comparing the performance of the devices, with phantom and in vivo experiments.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Lorenzo Cortese, Marta Zanoletti, Marco Pagliazzi, Umut Karadeniz, M. Atif Yaqub, David R. Busch, Jaume Mesquida, and Turgut Durduran "Performance assessment of commercial continuous-wave near-infrared spectroscopy devices for the multi-center HEMOCOVID-19 clinical study", Proc. SPIE PC11951, Design and Quality for Biomedical Technologies XV, PC119510C (7 March 2022); https://doi.org/10.1117/12.2608215
Advertisement
Advertisement
KEYWORDS
Continuous wave operation

Near infrared spectroscopy

Measurement devices

In vivo imaging

Medical devices

Oxygen

Reliability

Back to Top